Drug major Lupin will launch 25 products in US this fiscal
Drug major Lupin will launch 25 products in US this fiscal
Share:

Lupin,the drug major expects to launch almost 25 products in the US market in 2016-17 that the company expects to be the main driver for its revenue growth, going forward.

Lupin CEO Vinita Gupta said,"We expect to launch a good number of products between India and Gavis (US). We are hoping to launch 25 plus products, FDA permitting. So, a good number of launches that we expect for the year,"

In the present year, separately from the Gavis portfolio, Fortamet and Glumetza, the company expects to launch products like Minastrin and Epzicom.

While `Gupta added that, "We expect to start seeing launches on the dermatology front this year, and next year, certainly good impact from our dermatology pipeline both out of India as well as Somerset,"

As Lupin announced,"So, I would say in the next two years, a combination of our products in particular semi-exclusive, exclusive plus dermatology pipeline out of India as well as Gavis plus the controlled substances should add very nicely to our revenues as well as profitability."
 

 

Join NewsTrack Whatsapp group
Related News